Get the app
US › Healthcare

XBiotech Inc (XBIT)

US · Healthcare · Biotechnology

$2.12-1.85%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-6.7M
EPS
$-0.22

Key statistics

Market cap
$65.9M
Forward P/E
0.0
P/B
0.52
Book value
$4.21
EPS (TTM)
$-1.47
52-week high
$3.44
52-week low
$2.09
50-day MA
$2.23
200-day MA
$2.36
Beta
0.80

Analyst view

with an average price target of $18.00.

Shareholding

Insiders
36.87%
Institutions
6.73%

Largest institutional holders

FundStake
BlackRock Inc1.05%
Geode Capital Management, LLC0.70%
Vanguard Capital Management, LLC0.66%
RBF LLC0.65%
Morgan Stanley - Brokerage Accounts0.48%
Bridgeway Capital Management, LLC0.32%
Vanguard Fiduciary Trust Co0.30%
Millennium Management LLC0.26%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for XBiotech Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.